Cyclophosphamide injection - Nevakar
Latest Information Update: 23 Aug 2023
At a glance
- Originator Nevakar
- Class Antineoplastics; Cyclophosphamides; Myeloablative agonists; Small molecules
- Mechanism of Action Alkylating agents; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Cancer